J&J Teams With Advinus For Drug Discovery In India
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's Tata Group company Advinus has formed a drug discovery and early clinical development tie-up with Ortho-McNeil-Janssen Pharmaceuticals, an arm of U.S.-based Johnson & Johnson
You may also be interested in...
J&J Intensifies Search For Drugs With A New Development Center In Mumbai
The new facility is an important milestone for the company, and it will support 80 percent of J&J's global late-phase drugs execution, global development exec says.
J&J Intensifies Search For Drugs With A New Development Center In Mumbai
MUMBAI - From forging alliances for drug discovery research in India, Johnson & Johnson has taken one step forward and established in what it called "the first of its kind" late-phase new chemical entity Analytical and Pharmaceutical Development Center at its North Mumbai facility
J&J Intensifies Search For Drugs With A New Development Center In Mumbai
The new facility is an important milestone for the company, and it will support 80 percent of J&J's global late-phase drugs execution, global development exec says.